Terrace Hill Group PLC
31 October 2002
TERRACE HILL GROUP PLC (The 'Company')
Sale of Investment Property
The Company has, subject to head landlord's consent, sold to Northway House
Limited an investment property (previously refurbished by the Company) being a
9,032 sq ft office building at Fulwood Place, London, WC1 let out in August, at
a price of £4.160 million payable in cash with completion expected in late
November.
This is a substantial transaction in terms of the AIM Rules and the following
information is given.
The carrying value of the property is £4.011 million. The cost of acquisition
and redevelopment was £2.815 million. Current revenue profitability has been
nil as the tenant is in an initial rent free period. The proceeds of the sale
will be used to reduce gearing. The effect on the Company is to improve
profitability.
Contacts:
Ross Macdonald, Joint Managing Director, Terrace Hill Group Plc 0141 332 2014
Alasdair Robinson, Noble & Company Limited 0131 225 9677
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.